Skip to content
etf.net

Launched

GraniteShares YieldBOOST Biotech ETF

BIOYNasdaqGraniteSharesF

$19.03−0.16 (−0.82%)

As of Nov 10, 2026, 11:24 AM ET

F21/ 100

Rank 21 of 22 in Sector Option Income

F21/100Rank 21 of 22inSector Option Income
Intraday session: down, 24 prints from 19.19 to 19.03. Range 19.03 to 19.25. Use the arrow keys to read each point.19.1019.1519.2510 AM12 PM2 PM4 PM
Expense ratio
14.98%
Fund size
$2M
1Y total return
No data
Yield · Last 12 months
No data
Holdings
7
Avg volume · 30D
2.54K sh
52W range
low $18.76high $25.28
Launched

The ETF.net BIOY Grade

Based on 4 of 6 pillars

F

Score 21 out of 100

Category
Sector Option Income⁠
Rank
21 of 22
Six-pillar profile for BIOY. Scores out of 100: Cost 0, Risk 60, Mission not scored, Tradability 24, Holdings not scored, Durability 27. Strongest: Risk (60). Weakest: Cost (0). Based on 4 of 6 pillars.

Score 21 of 100 falls in the F band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

Very small fund, grade capped at C.

The cap holds the Score at 40 or below, so B and A are out of reach.

The pillars earned
21
This cap took
0
Published Score
21 Grade F

  • Cost

    The fund’s net expense ratio, ranked against its category.
    F0 out of 100
    Rank 22 of 22

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B60 out of 100
    Rank 9 of 22

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    F24 out of 100
    Rank 21 of 22

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    Not scored

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    D27 out of 100
    Rank 20 of 22

Our read on BIOY

ETF.net Research

In short

FMost sector income funds sell calls on the sector itself. BIOY goes one level up: it sells puts on a 3x leveraged biotech ETF, mining the fat premiums that come with one of the market's twitchiest wrappers, and pays cash out weekly.

Stated mandate

The Fund seeks to generate three times the income from selling options on the S&P Biotechnology Select Industry Index through options on leveraged ETFs, while also seeking exposure to the leveraged ETF’s performance subject to a cap.

Why people hold it

  • The income engine is the whole point: writing puts on a 3x biotech ETF harvests the elevated implied volatility leveraged funds throw off, with distributions paid weekly.graniteshares.com
  • It doesn't hold the leveraged biotech ETF. Exposure runs through the options book, aiming at 3x the income from selling options on the S&P Biotechnology Select Industry Index.graniteshares.com
  • One ticker replaces a standing options program: strike selection, short-dated expiries and the weekly roll are handled inside a 1940 Act fund.graniteshares.com
  • GraniteShares discloses that payouts can include return of capital, so the character of each distribution is documented rather than left to guesswork.graniteshares.com

Worth knowing

  • At 1.07%, the fee runs about triple the 0.35% median of its sector-overlay peer group, where the State Street Premium Income funds (XLVI, XLUI) sit.
  • The payoff shape is lopsided: upside is capped by design while the put book absorbs the downside of a 3x daily biotech ETF, a tool built for one-day moves.
  • Small and thinly traded, and it only started trading in 2026, so there is little history behind it and execution costs deserve attention.

BIOY Performance

Launched May 5, 2026

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.Not enough history yet.Not enough history yet.
BIOY$10,587
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$9,758
Aug 7, 2026 to Nov 9, 2026. BIOY $10,587. SPY $9,758. Use the arrow keys to read each point.$9,500$10,000$10,500Aug 2026Sep 2026Nov 2026

Aug 7, 2026 – Nov 9, 2026

Returns run to the Nov 9, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for BIOY. Periods over one year show the average yearly return.
PeriodBIOY
Year to dateFund launched this yearNo data
1 month0.0%
3 months+5.9%
1 yearFund is under 1 year oldNo data
3 yearsFund is under 3 years oldper yearNo data
5 yearsFund is under 5 years oldper yearNo data
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for BIOY
YearReturn barBIOY
2026 YTD+4.7%

Since listing, May 5, 2026

BIOY in the news

BIOY Dividends

Upcoming payment
$0.22 per share
Pays on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Weekly

Distribution data unavailable.

Distribution history

2026

One bar per payment. 27 payments in 2026 YTD. May 8, 2026 $0.28; May 15, 2026 $0.29; May 22, 2026 $0.28; May 29, 2026 $0.27; Jun 5, 2026 $0.27; Jun 12, 2026 $0.26; Jun 18, 2026 $0.27; Jun 26, 2026 $0.27; Jul 2, 2026 $0.26; Jul 10, 2026 $0.26; Jul 17, 2026 $0.25; Jul 24, 2026 $0.25; Jul 31, 2026 $0.24; Aug 7, 2026 $0.24; Aug 14, 2026 $0.25; Aug 21, 2026 $0.25; Aug 28, 2026 $0.25; Sep 4, 2026 $0.25; Sep 11, 2026 $0.25; Sep 18, 2026 $0.23; Sep 25, 2026 $0.23; Oct 2, 2026 $0.23; Oct 9, 2026 $0.23; Oct 16, 2026 $0.23; Oct 23, 2026 $0.23; Oct 30, 2026 $0.23; Nov 6, 2026 $0.22. Use the arrow keys to read each point.2026YTD
Ex-datePay dateAmount per share
Nov 6, 2026Pays Nov 10, 2026$0.22
Oct 30, 2026Nov 3, 2026$0.23
Oct 23, 2026Oct 27, 2026$0.23
Oct 16, 2026Oct 20, 2026$0.23
Oct 9, 2026Oct 14, 2026$0.23
Oct 2, 2026Oct 6, 2026$0.23
Sep 25, 2026Sep 29, 2026$0.23
Sep 18, 2026Sep 22, 2026$0.23
Sep 11, 2026Sep 15, 2026$0.25
Sep 4, 2026Sep 9, 2026$0.25
Aug 28, 2026Sep 1, 2026$0.25
Aug 21, 2026Aug 25, 2026$0.25

See all 27 payments⁠

BIOY Risk

Risk pillarB60 out of 100Rank 9 of 22 in Sector Option Income
How much the fund’s monthly returns vary, scaled to a year.
Launched May 2026; fills in after 12 months
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
Launched May 2026; fills in after 12 months
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
Launched May 2026; fills in after 12 months
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.56
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

BIOY Cost

Compare BIOY and XLEI

Overpaying vs XLEI, tied cheapest in Sector Option Income

$68,172

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • BIOY 14.98%

    $75,298

  • XLEI 0.35% Tied cheapest

    $7,126

$10,000
30 years

Cost over time

  • BIOY 14.98%
  • XLEI 0.35%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$20K$40K$60K$80K051015202530BIOY $75,298XLEI $7,126

Year by year

YearBIOYXLEIOverpaying
10$15,318$634$14,684
20$36,802$2,454$34,348
30$75,298$7,126$68,172

Other funds in Sector Option Income

See others